QGRW LN
WisdomTree US Quality Growth UCITS ETF - USD Acc

Published 4 February 2025
Director, Quantitative Research
For years, the NASDAQ 100 has been the dominant benchmark for growth investors in the US markets, known for its heavy exposure to technology and innovation-driven companies. The methodology is straightforward—the 100 largest non-financial companies by market capitalisation listed on the NASDAQ exchange are selected for inclusion, with constituents weighted by modified market capitalisation.
However, this simplicity can come with trade-offs. Since the NASDAQ 100 does not apply fundamental selection criteria, mature, slow-growth companies can enter the index purely due to their size, potentially diluting the ‘growth’ exposure that investors seek.
In contrast, the WisdomTree US Quality Growth UCITS Index deploys a fundamentals-based selection process, identifying high-growth companies with strong profitability metrics across all major US exchanges. This broader and more refined methodology has led to outperformance of more than 12.5% over the NASDAQ 100 in 20241, a year when the NASDAQ 100 itself posted strong gains.

Source: FactSet, Bloomberg. Returns from 30 November 2022 to 31 December 2024, are derived from the Net Total Return series. The WisdomTree US Quality Growth Strategy is represented by backtested performance followed by live performance of the UCITS Index (WTQGRWUN Index). The strategy went live in the US under the index name WTQGRWTR Index on 30 November 2022. Historical performance is not an indication of future performance, and any investment may go down in value.
WisdomTree US Quality Growth | NASDAQ 100 | Russell 1000 Growth Index | S&P 500 Index | |
|---|---|---|---|---|
CAGR | 38.13% | 31.44% | 30.75% | 20.46% |
Volatility | 19.72% | 18.44% | 16.95% | 13.13% |
Sharpe | 1.93 | 1.70 | 1.81 | 1.56 |
Beta | 1.39 | 1.31 | 1.23 | 1.00 |
Overlap by Count | |||
|---|---|---|---|
Securities in WisdomTree Index | Constituent Overlap Count | Securities in NASDAQ 100 | |
100 | 43 | 100 | |
Overlap by Weight | |||
|---|---|---|---|
Common Securities Weight in WisdomTree Index | Weight Overlap between WisdomTree Index and NASDAQ 100 | Common Securities Weight in NASDAQ 100 | |
84.2% | 62.4% | 71.2% | |
Source: WisdomTree, NASDAQ, as of 31 December 2024. You cannot invest directly in an index.
While there is significant overlap in holdings, WisdomTree's selection methodology results in a differentiated portfolio, emphasising earnings and sales growth as key factors.
To highlight the contrast in methodology, below are the five largest unique holdings in each index.
Top Unique Stocks in the WisdomTree US Quality Growth Index:
Top Unique Stocks in the NASDAQ 100 (excluded from WisdomTree due to profitability and growth screens):

Source: WisdomTree, FactSet, Bloomberg. As of 31 December 2024. You cannot invest directly in an index.
A few observations from Figure 3:
By applying a fundamentals-based selection process across all US exchanges, the WisdomTree US Quality Growth UCITS Index provides a better proxy for growth investing compared to traditional market-cap-weighted indices like the NASDAQ 100.
WisdomTree US Quality Growth UCITS Index:
For investors seeking high-quality growth opportunities, the WisdomTree US Quality Growth UCITS ETF seeks to track the price and yield performance of the WisdomTree US Quality Growth Index. With it’s fundamentals-driven approach the WisdomTree US Quality Growth UCITS ETF could offer a superior way to access long-term, sustainable growth.
1 Source: FactSet, Bloomberg. Returns from 30 November 2022, to 31 December 2024.
WisdomTree US Quality Growth UCITS ETF - USD Acc

Director, Quantitative Research
Ayush Babel is the Director of Quantitative Research in WisdomTree's multi-asset quantitative research and index teams. In this role, he focuses on developing innovative quantitative strategies across various asset classes while supporting WisdomTree's diverse range of products. His expertise spans factor exploration, portfolio construction and optimization, quantitative investment research, and product development.
With over a decade of experience in the financial services industry, Ayush has held investment research roles at J.P. Morgan and Franklin Templeton. At these institutions, he was responsible for developing and managing equity and fixed income smart beta products, as well as cross-asset risk premia solutions for global institutional and retail clients. His experience covers a broad spectrum of asset classes and investment styles.
Ayush holds a bachelor's in Engineering Physics and a master’s degree in Nanoscience from the Indian Institute of Technology, Bombay.